Address: Mustafa Kemal Mahallesi Dumlupınar Bulvarı (Eskişehir Yolu 7.Km) 2151.Cadde No:154 06510 Çankaya /ANKARA
Tel: +90 312 201 50 00
Web: http://www.sanayi.gov.tr/Default.aspx?lng=en
To contribute to Turkey’s goal of becoming one of the ten most developed countries in the world with a competitive economy based on entrepreneurship, innovation, scientific development and technological production with high added value.
With a view to enhance the competitiveness of the country in the international level:
To develop and implement policies, strategies, plans and programs on science, industry and technology,
To promote the adoption of a scientific approach and understanding in the society as the society is transformed into an information society,
To provide the necessary conditions for a safe, sustainable, efficient, environmental-friendly production which is based on high technology and which lessens the dependency of the country to foreign sources,
To promote cooperation between the universities and industry, to strengthen the technological infrastructure and to enhance competitiveness through supporting entrepreneurship, innovation, R&D activities particularly in the SMEs,
To safeguard secure product circulation and supply in order to prevent unfair competition and protect the consumers.
Within the Ministry’s wide scope of activities aimed at promoting Turkish various industries and trade, what special role does the pharmaceutical sector play within these aspirations? The world we live…
As the international community continues its quest to vaccinate the global population against COVID-19, shortages of already approved vaccines have put many countries on the waiting list. Approved vaccines from…
Ümit Dereli is secretary general of the Turkish Association of Research-Based Pharmaceutical Companies (AIFD), which has 35 multinational member companies that together account for almost 50 percent of the Turkish…
When Abdi Ibrahim acquired a 28.5 percent stake in Swiss biotech OM Pharma in September 2020, it represented a historic moment for Turkey’s pharma industry; the first time a Turkish…
There is perhaps no Turkish company in the healthcare sector that is more ambitious than Acıbadem. Not only has the private hospital group revolutionized healthcare in Turkey with its advanced…
Dr Ferhat Farsi, CEO and founding partner of CinnaGen İlaç, shares his experience working for the largest biotech in the MENA region, Turkey’s important role within the global group, and…
Şükran Tümay, a senior partner at executive search and assessment firm Stanton Chase in Turkey, highlights the evolving profiles she looks for when hiring country managers for healthcare and the…
Turkey – home to an 80 million-strong population, a substantial pharmaceuticals market and a universal healthcare system that is the envy of its neighbours – stands as one of the…
Bucking a global trend for increased focus on outpatient and preventative care, Turkey is doubling down on hospital investment. Throughout many of the healthcare systems in North America and Europe, there…
Armağan Vurdu, general secretary of the Istanbul Minerals and Metals Exporters Association (IMMIB) highlights the strategic importance of the chemical and pharmaceutical sectors in Turkey’s exports. He underscores pharma’s role…
Ozlem Fidanci, CEO of the Middle East and Turkey at Philips, shares the collaborative approach Philips has implemented in Turkey and its successes, provides insights into future collaborations and discusses…
Yelda Ulu Colin, general manager of GE Healthcare in Turkey, offers her insider take on the country’s city hospitals project, highlighting the strengths of the Turkish PPP model and ultimately…
Seizing the cost competitiveness of the Turkish market and the government’s nurturing of local manufacturing, Turkish companies are looking to harness their geographic positioning and export to developed and developing…
See our Cookie Privacy Policy Here
